An Analysis of the Fixed-Dose Combinations Authorized by the European Union, 2009–2014: A Focus on Benefit-Risk and Clinical Development Conditions

被引:0
|
作者
Dominik Sawicki-Wrzask
Mikael Thomsen
Ole J. Bjerrum
机构
[1] University of Copenhagen,Institute for Drug Design and Pharmacology, Faculty of Health and Medical Sciences
[2] Contera Pharma,undefined
关键词
combination therapy; new therapeutic entity; regulatory guidelines; innovative development; unmet medical need; reimbursement;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:553 / 559
页数:6
相关论文
共 6 条
  • [1] An Analysis of the Fixed-Dose Combinations Authorized by the European Union, 2009-2014: A Focus on Benefit-Risk and Clinical Development Conditions
    Sawicki-Wrzask, Dominik
    Thomsen, Mikael
    Bjerrum, Ole J.
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (04) : 553 - 559
  • [2] Body of evidence and approaches applied in the clinical development programme of fixed-dose combinations in the European Union from 2010 to 2016
    Nohr-Nielsen, Asbjorn
    De Bruin, Marie Louise
    Thomsen, Mikael
    Pipper, Christian Bressen
    Lange, Theis
    Bjerrum, Ole Jannik
    Lund, Trine Meldgaard
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (08) : 1829 - 1840
  • [3] Topical fixed-dose combinations: Current in vitro methodologies for pre-clinical development
    Veloso, Claudia
    Videira, Romeu A.
    Andrade, Paula B.
    Cardoso, Catarina
    Vitorino, Carla
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 617
  • [4] Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions: The European Union Perspective
    Muehlbacher, Axel C.
    Juhnke, Christin
    Beyer, Andrea R.
    Garner, Sarah
    [J]. VALUE IN HEALTH, 2016, 19 (06) : 734 - 740
  • [5] Safety and tolerability of fixed-dose combinations of ibuprofen and acetaminophen: pooled analysis of phase 1-3 clinical trials
    Su, Jiangfeng
    Leyva, Rina
    Kellstein, David
    Cruz-Rivera, Mario
    Meeves, Suzanne
    [J]. POSTGRADUATE MEDICINE, 2021, 133 (05) : 565 - 571
  • [6] Analysis of Clinical Dose-Response in Small-Molecule Drug Development: 2009-2014
    Thomas, Neal
    Roy, Dooti
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2017, 9 (02): : 137 - 146